对补充剂的潜在相对生物可访问性进行比较 - - 实验室研究
Justyna Ośko1, Wiktoria Pierlejewska1, Małgorzata Grembecka1
1Department of Bromatology, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
Nutrients
|June 28, 2023
概括
补充剂中的 (Zn) 生物可访问性差异很大,二甲基酸盐显示最高,硫酸盐显示最低. 许多补充剂超过申报的含量和可容忍的上限摄入量 (UL).
科学领域:
- 营养科学 营养科学
- 分析化学 分析化学
背景情况:
- (Zn) 摄入的饮食补充剂被广泛使用.
- 的化学形式和剂量的变化可能会影响其生物可用性.
- 确保准确的标签和安全的摄入水平对于公共健康至关重要.
研究的目的:
- 评估各种补充剂中的的体外生物可访问性.
- 为了比较Zn在不同药物形式,含量,剂量和化学形式中的生物可访问性.
- 为了验证公布的 Zn 含量准确性和超过可容忍上摄入水平 (UL) 的潜在风险.
主要方法:
- 在体外消化模型模拟人类胃肠道条件.
- 火焰原子吸收光谱 (FAAS) 用于精确确定含量.
- 验证FAAS方法的线性,恢复和准确性.
主要成果:
- 的生物可访问性从1.1%到9.4%不等,其中二甲酸盐是最生物可访问的,而硫酸是最不容易获得的.
- 十种补充剂中有九种含有高于声明的含量 (高达161%).
- 五种补充剂超过了Zn (123-146%) 的可容忍上限摄入水平 (UL).
结论:
- 从食补充剂中获得的生物可访问性存在显著的变化.
- 不准确的标签和潜在的过度消费Zn是分析补充剂中普遍存在的问题.
- 遵守波兰,欧洲和USP指南需要仔细考虑的形式和剂量.
相关概念视频
Methods for Studying Drug Absorption: In vitro
262
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
262
Bioavailability: Overview
2.9K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.9K
Factors Influencing Bioavailability: First-Pass Elimination
6.5K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.5K
Methods for Studying Drug Absorption: In situ
272
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
272
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
235
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
235


